Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-07

Clinical Trial Update: Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy of artesunate-amodiaquine and artemether-lumefantrine for treating uncomplicated Plasmodium falciparum malaria in L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)
  • Artesunate-amodiaquine (artesunate-amodiaquine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Plasmodium Falciparum, Malaria | Phase 4 | Status: COMPLETED